ReviewPharmaceutics2023

Mesoporous Silica-Based Nanoplatforms Are Theranostic Agents for the Treatment of Inflammatory Disorders.

Bhagavathi Sundaram Sivamaruthi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.